Proteomic profiling of FBXW7 ‐mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteomic profiling of FBXW7 ‐mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target

Published:2020-04-05 Issue:11 Volume:9 Page:3863-3874
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Urick Mary Ellen¹^ORCID,Bell Daphne W.¹^ORCID

Affiliation:

1. Cancer Genetics and Comparative Genomics Branch National Human Genome Research Institute National Institutes of Health Bethesda MD USA

Funder

Intramural Program of the National Human Genome Research Institute, NIH

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3013

Reference42 articles.

1. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

2. Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases

3. Clinical actionability of molecular targets in endometrial cancer

4. Integrated genomic characterization of endometrial carcinoma

5. Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large-scale genomic analysis of the domestic dog informs biological discovery;Genome Research;2024-06

2. The Role of FBXW7 in Gynecologic Malignancies;Cells;2023-05-17

3. The Identification of Key Genes and Biological Pathways in Polycystic Ovary Syndrome and its Complications by Next Generation Squancing (NGS) and Bioinformatics Analysis;2023-01-02

4. Comprehensive Study of Human FBXW7 Deleterious nsSNP’s Functional Inference and Susceptibility to Gynaecological Cancer;Applied Biochemistry and Biotechnology;2021-11-24

5. Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?;Cancers;2021-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3